Application of cd1c in the diagnosis of bacterial-negative pulmonary tuberculosis
A tuberculosis, bacteria-negative technology, applied in the application field of CD1c in the diagnosis of bacteria-negative pulmonary tuberculosis
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0020] Example 1 Down-regulation of CD1c expression in DCs infected with MTB
[0021] Isolation of PBMC from healthy volunteers, immunomagnetic separation of CD14 + Monocytes were induced with GM-CSF and IL-4 to differentiate into DCs, and the resulting DCs were infected with MTB. After 72 hours, the expression level of CD1c in DC was detected by real-time fluorescent quantitative PCR.
[0022] Test results such as figure 1 As shown, it can be seen that the expression level of CD1c in DC after MTB infection is significantly reduced, indicating that MTB infection inhibits the expression of CD1c.
Embodiment 2
[0023] Example 2 Down-regulation of CD1c expression in DCs of bacterium-negative pulmonary tuberculosis patients
[0024] Isolation of PBMCs from bacterium-negative pulmonary tuberculosis patients and healthy volunteers, immunomagnetic separation of CD14 + For monocytes, GM-CSF and IL-4 were used to induce monocytes to differentiate into DCs. After 72 hours, real-time fluorescent quantitative PCR was used to detect the expression of CD1c.
[0025] Test results such as figure 2 As shown, it can be seen that the expression level of CD1c in the DCs of bacteria-negative pulmonary tuberculosis patients was significantly lower than that of healthy volunteers ( P <0.05).
Embodiment 3
[0026] Example 3 Down-regulation of CD1c expression in PBMCs of patients with bacterium-negative pulmonary tuberculosis
[0027] PBMCs from 119 bacterium-negative pulmonary tuberculosis patients and healthy volunteers were isolated, and the expression of CD1c on the cell surface was detected by flow cytometry.
[0028] Test results such as image 3 As shown, it can be seen from it that the PBMCs expressing CD1c on the cell surface of bacterium-negative pulmonary tuberculosis patients were 0.9%, which was significantly lower than that of healthy volunteers (9.2%), as shown in image 3 Shown in A; the average fluorescence intensity test results also show that the fluorescence intensity of CD1c expression in PBMCs of bacterium-negative pulmonary tuberculosis patients is significantly lower than that of healthy volunteers ( P image 3 Shown in B; it shows that the expression level of CD1c in PBMC of patients with bacterial negative pulmonary tuberculosis is significantly lower th...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com